Seattle biotech working on treating Alzheimer's raises $44M, filing shows
July 27, 2022 at 15:16 PM EDT
The funding follows a $23.1 million Series A round in January 2021.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|